Top-4 stocks in Friday's premarket 🔥

Good Morning! Hey, there! It's Chris from Elite Trade Club, here to give you this morning's premarket trading news. Happy Friday! It's August 25th. I hope you have a great weekend. Now, let's get ready to trade! Markets 📈 Stocks pulled back on Thursday, and the big-name indexes all suffered losses exceeding 1.0%. The Nasdaq was the leading decliner with a 1.8% loss, while the S&P fell 1.3%, and the Dow lost 1.0%. The small-cap Russel 2K closed 1.2% lower. Today, futures are on the rise in early trading. S&P 500 contracts are up 0.2%. Sponsored [This Tiny Biotech Could Skyrocket 🚀]( One of the most promising micro-cap biotech stocks on the market is heating up after a new bout of clinical data. Just yesterday, the company shared positive new clinical results from trials of two promising drug candidates. The drugs in question target social anxiety disorder and PTSD, two of the most common modern day ailments, so sales could be huge if approved. With a potential approval around the corner, now could be an excellent time to get in for cheap. [Get the Ticker and the Complete Clinical Update Here]( Premarket Highlights 🔎 ⚪ All's Quiet. It's a quiet premarket, and there's no major earnings or economic events on today's calendar. What to Watch Today 👀 Hawaiian Electric Embattled utility Hawaiian Electric [HE] could be a key player to watch in today's session. Shares are down more than 20% after a county in Maui filed a suit against the firm alleging its power lines cause the devastating wildfires on the island. The company also recently announced plans to suspend its dividend in order to shore up its cash position. Shares were already down more than 70% over the past month, as of Thursday's close. Major Earnings 💰 Hibbett, Inc. [HIBB] ... AM Akebia Therapeutics, Inc. [AKBA] ... AM Ideanomics, Inc. [IDEX] ... PM Economy 🏗 - U Mich consumer sentiment, final [Aug] ... 10:00a Running Hot 🔥 Gainers - Sellas Life [SLS] >> +18.7% - VERB TECH [VERB] >> +15.9% - Orgenesis [ORGS] >> +14.9% - CompoSecure [CMPO] >> +16.7% Decliners - Domo [DOMO] >> (31.4%) - Prime Number Acquisition [PNAC] >> (32.8%) - Myomo [MYO] >> (21.6%) - Hawaiian Electric [HE] >> (17.3%) BK Technologies [BKTI] - Last Close: $11.52 BK Technologies is on a hot streak after a recent insider buy. On August 17th, a Form 4 filing revealed CEO John Suzuki bought 4,228 shares of common stock at an average purchase price of $10.50 per share. The news sparked a rally in shares of BKTI that lasted until Tuesday of this week, but shares have pulled back over the past two sessions. However, it appears the pullback may have been overdone because BKTI is rebounding in today's premarket, despite no major news. BKTI is one of this morning's top gainers with a 16.8% advance. My Take: BKTI appears to be enjoying some short-term support from dedicated swing traders, but I think it will take more than an insider buy to lift share prices back to their 52-week high. T2 Biosystems [TTOO] - Last Close: $0.3519 T2 Bio is rebounding after a steep sell-off. The micro-float biotech announced plans for a public offering of 141 million shares of common stock early Thursday, and the market wasn't pleased. Shares of TTOO fell 26.3% on the news as investors gauged the impact of potential dilution of shareholder value. However, the declines didn't last long, and TTOO is recapturing a lot of its lost ground in today's premarket. TTOO is up 20.8% on elevated premarket trading volume. My Take: TTOO looks like a stinker. It had a good run earlier this month, but the rally quickly dissipated. I don't think these gains will last, either. YS Biopharma [YS] - Last Close: $0.779 YS Bio is climbing after a late Thursday announcement. After yesterday's close, the tiny biotech said its chairman and CEO had purchased upwards of 475,000 shares of common stock on the open market. Founder & chairman Yi Zhang purchased 429,188 shares at an average cost of $1.407, while CEO Dr. Hui Shao bought 46,300 at $1.46 per share. Combined, the total value of the insider buys adds up to more than $671,000. YS is leading today's premarket movers with a 53.4% gain on elevated trading volume. My Take: Not much to write home about with YS. Its chart is pretty ugly, and I don't think the insider buy will do much to improve its long-term trajectory. Comera Life Sciences [CMRA] - Last Close: $0.499 Comera Life just attracted a significant new backer. After Thursday's close, a Form SC 13G filing revealed Nicholas Singer and Purchase Capital has acquired a 5.17% stake in the company. The filing came just a week after Comera Life published a new study reinforcing caffeine's viscosity-reducing capabilities. CMRA is up 20.2% in the wake of the Purchase Capital filing. My Take: It's worth paying attention whenever you see the Smart Money snatching up an obscure biotech stock. There's a good chance their analysts know something we don't. That's it for today! Thanks for reading, and good luck out there! Best Regards, Chris D. -- Elite Trade Club P.S... Want alerts delivered straight to your cell every morning for free?* Text ELITE to 47121 to sign up now and get our watchlists sent directly to your phone! Or text CLOSE to 47121 to get on the mobile alert list for our Closing Bell Roundup report, featuring the day's top winners and losers. *Standard message/carrier rates may apply. Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside of these emails. [Bots click here]( 1969 S. ALAFAYA TRAIL Orlando FL 32828 USA [Unsubscribe]( | [Change Subscriber Options](